These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15840744

  • 1. The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP, PREVEND Study Group.
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4198-204. PubMed ID: 15840744
    [Abstract] [Full Text] [Related]

  • 2. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP, PREVEND Study Group.
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group.
    J Clin Lipidol; 2013 Sep; 7(1):56-64. PubMed ID: 23351584
    [Abstract] [Full Text] [Related]

  • 6. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E, Klerkx AH, Le Goff W, Tanck MW, Lagarde JP, Jukema JW, Kastelein JJ, Chapman MJ, Guerin M.
    Hum Mol Genet; 2005 Sep 15; 14(18):2607-18. PubMed ID: 16049032
    [Abstract] [Full Text] [Related]

  • 10. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.
    Cell Biochem Funct; 2009 Oct 15; 27(7):452-7. PubMed ID: 19784962
    [Abstract] [Full Text] [Related]

  • 11. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
    Eiriksdottir G, Bolla MK, Thorsson B, Sigurdsson G, Humphries SE, Gudnason V.
    Atherosclerosis; 2001 Nov 15; 159(1):187-92. PubMed ID: 11689220
    [Abstract] [Full Text] [Related]

  • 12. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment.
    Dullaart RP, van den Berg G, van der Knaap AM, Dijck-Brouwer J, Dallinga-Thie GM, Zelissen PM, Sluiter WJ, van Beek AP.
    Eur J Endocrinol; 2010 Feb 15; 162(2):227-34. PubMed ID: 19926784
    [Abstract] [Full Text] [Related]

  • 13. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Feb 15; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J, Mao YM, Cong HL, Liu Y, Zhang N, Chen Q, Liu T, Cui RZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May 15; 41(5):399-405. PubMed ID: 24021123
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T, Vohl MC, Houde I, Lachance JG, Noël R, Després JP, Douville P, Bergeron J.
    Nephron; 2000 Apr 15; 84(4):333-41. PubMed ID: 10754410
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.
    Dullaart RP, Schols JL, van der Steege G, Zelissen PM, Sluiter WJ, van Beek AP.
    Clin Endocrinol (Oxf); 2008 Sep 15; 69(3):359-66. PubMed ID: 18221399
    [Abstract] [Full Text] [Related]

  • 20. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
    Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ.
    Circulation; 2005 Jan 25; 111(3):278-87. PubMed ID: 15655129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.